R
Raphael Pharmaceutical Inc
OTC:RAPH
Raphael Pharmaceutical Inc
OTC:RAPH
Price:
1.4
USD
Market Closed
Market Cap:
$28.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Raphael Pharmaceutical Inc
OTC:RAPH
|
US |
|
AFR Nuventure Resources Inc
XTSX:ABC
|
CA |
|
R
|
Reliant Holdings Inc
OTC:RELT
|
US |
|
I
|
Imperial Resources Inc
OTC:IPRC
|
US |
|
I
|
indiePub Entertainment Inc
OTC:IPUB
|
US |
|
Mdm Permian Inc
OTC:MDMP
|
US |
|
Boryszew SA
F:BOW
|
PL |
|
M
|
Marine Bancorp of Florida Inc
OTC:MBOF
|
US |
|
L
|
LeapCharger Corp
OTC:LCCN
|
US |
|
Prophase Labs Inc
OTC:PRPH
|
US |
|
Rayont Inc
OTC:RAYT
|
US |
|
Frontier Developments PLC
F:5FD
|
UK |
|
CI Com SA
SIX:CIE
|
CH |
|
I
|
Ipackets International Inc
OTC:IPKL
|
CA |
|
T
|
Telecom Argentina SA
F:TEO
|
AR |
|
Alfa Energi Investama Tbk PT
IDX:FIRE
|
ID |
|
S
|
Solucorp Industries Ltd
OTC:SLUP
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of RAPH.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RAPH
Multiples-Based Value
Base Case
Not Available
